The validity of decision rules for selecting women with primary osteoporosis for bone mineral density testing

被引:0
|
作者
Suzanne M. Cadarette
Warren J. McIsaac
Gillian A. Hawker
Liisa Jaakkimainen
Alison Culbert
Gihane Zarifa
Ebele Ola
Susan B. Jaglal
机构
[1] University of Toronto,Department of Health Policy, Management and Evaluation
[2] Sunnybrook and Women’s College Health Sciences Centre,Osteoporosis Research Program, Women’s College Ambulatory Care Centre
[3] University of Toronto,Department of Family and Community Medicine
[4] Mount Sinai Family Medicine Centre,Division of Rheumatology, Women’s College Ambulatory Care Centre
[5] Sunnybrook and Women’s College Health Sciences Centre,Department of Family and Community Medicine
[6] Institute for Clinical Evaluative Sciences in Ontario,Graduate Department of Rehabilitation Science
[7] Sunnybrook and Women’s College Health Sciences Centre,undefined
[8] University of Toronto,undefined
来源
关键词
Decision aids; Osteoporosis; Screening; Sensitivity; Specificity; Women;
D O I
暂无
中图分类号
学科分类号
摘要
The purpose of this study was to determine the validity of the Osteoporosis Risk Assessment Instrument (ORAI), Osteoporosis Self-Assessment Tool (OST) chart and equation, and a criterion based on body weight for identifying women with asymptomatic primary osteoporosis. Prospective recruitment and chart abstractions from family practices of three University affiliated hospitals were completed for women aged 45 years or more with baseline bone mineral density (BMD) testing results by dual energy X-ray absorptiometry. Those taking bone active medication other than hormone therapy, with prior fragility fracture or with risk factors for secondary osteoporosis were excluded. Women were categorized as being normal, osteopenic or osteoporotic by lowest BMD T-score at either the femoral neck or lumbar spine (L1–L4). Sensitivity, specificity and area under the receiver operating characteristic (ROC) curve to identify those with osteoporosis were determined for each decision rule. The positive predictive value (PPV) for detecting osteoporosis after using a second cut point to convert each decision rule into a risk index (low, moderate or high risk) was also determined. The sensitivity of the decision rules to identify women with osteoporosis ranged from 92% to 95% and specificity from 35% to 46%. The area under the ROC curves were significantly better for the ORAI (0.80), OST chart (0.82) and OST equation (0.82) compared with the body weight criterion (0.73). PPV for detecting osteoporosis ranged from 30% to 58% among women deemed at high risk. These data confirm the validity of the ORAI, the OST chart and the OST equation as screening tools for BMD testing. Further evidence is required to confirm the validity of the body weight criterion.
引用
收藏
页码:361 / 366
页数:5
相关论文
共 50 条
  • [41] Evaluating bone mineral density in osteoporosis
    Gosfield, E
    Bonner, FJ
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2000, 79 (03) : 283 - 291
  • [42] BONE-MINERAL DENSITY IN OSTEOPOROSIS
    MAZESS, RB
    ETTINGER, M
    SCHULZ, E
    JOURNAL OF NUCLEAR MEDICINE, 1986, 27 (06) : 885 - 885
  • [43] Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis
    Stepan, Jan J.
    Burr, David B.
    Pavo, Imre
    Sipos, Adrien
    Michalska, Dana
    Li, Jiliang
    Fahrleitner-Pammer, Astrid
    Petto, Helmut
    Westmore, Michael
    Michalsky, David
    Sato, Masahiko
    Dobnig, Harald
    BONE, 2007, 41 (03) : 378 - 385
  • [44] Optimal Bone Mineral Density Testing Intervals in Korean Women
    Park, Seung Shin
    Kim, Jung Hee
    Choi, Hyung Jin
    Ku, Eu Jeong
    Lee, Seo Young
    Hong, A. Ram
    Cho, Nam H.
    Shin, Chan Soo
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 265 - 265
  • [45] Rate of mammography and bone mineral density testing in postmenopausal women
    Chen, Y
    Landsman, PB
    Brenneman, SK
    Teustch, SM
    Markson, LE
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S289 - S289
  • [46] Effect of Self-referral on Bone Mineral Density Testing and Osteoporosis Treatment
    Warriner, Amy H.
    Outman, Ryan C.
    Feldstein, Adrianne C.
    Roblin, Douglas W.
    Allison, Jeroan J.
    Curtis, Jeffrey R.
    Redden, David T.
    Rix, Mary M.
    Robinson, Brandi E.
    Rosales, Ana G.
    Safford, Monika M.
    Saag, Kenneth G.
    MEDICAL CARE, 2014, 52 (08) : 743 - 750
  • [47] Prevalence and Factors Associated With Osteoporosis and Bone Mineral Density Testing in Psoriatic Arthritis
    Kwok, Timothy S. H.
    Sutton, Mitchell
    Ye, Justine Yang
    Pereira, Daniel
    Chandran, Vinod
    Gladman, Dafna D.
    ARTHRITIS CARE & RESEARCH, 2022, 74 (06) : 1006 - 1012
  • [48] Association of plasma homocysteine with bone mineral density in postmenopausal women with osteoporosis or osteopenia affected by primary biliary cirrhosis
    Biagini, Maria Rosa
    Tozzi, Alessandro
    Bongini, Elena
    Capanni, Marco
    Galli, Andrea
    Milani, Stefano
    Surrenti, Calogero
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2007, 41 (06) : 635 - 635
  • [49] The influence of Visfatin, RBP-4 and insulin resistance on bone mineral density in women with treated primary osteoporosis
    Mihai, Gabriela
    Gasparik, Andrea Ildiko
    Pascanu, Ionela Maria
    Cevei, Mariana
    Hutanu, Adina
    Pop, Raluca-Monica
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2019, 31 (06) : 889 - 895
  • [50] The influence of Visfatin, RBP-4 and insulin resistance on bone mineral density in women with treated primary osteoporosis
    Gabriela Mihai
    Andrea Ildiko Gasparik
    Ionela Maria Pascanu
    Mariana Cevei
    Adina Hutanu
    Raluca-Monica Pop
    Aging Clinical and Experimental Research, 2019, 31 : 889 - 895